Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]
Kalorama estimates a $3.7 billion market for emerging diseases. This market is expected to grow to $4.9 billion in 2026. This is based on it’s latest report: Emerging Infectious Disease Market, released August 2022: https://kaloramainformation.com/product/emerging-infectious-disease-diagnostics-markets-and-trends-2022/ In 2015 the World Health Organization held a workshop on prioritization of pathogens “for accelerated R&D for severe emerging diseases […]
Global clinical laboratory services market is $168 billion and growing, finds new market research report by Kalorama Information Clinical laboratories are an essential part of the health industry, and as a result the global market for clinical laboratory services grew to an estimated $168.3 billion in 2021 (including $79 billion generated from markets outside the […]
Learn about these 5 key facts based on research featured in The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition (published April 2022), a recent report by Kalorama Information Watch the one minute video below for insights and important facts regarding the POC diagnostic testing market. And as always, Kalorama Information offers even more […]
A rapid scale-up of diagnostic testing for the novel coronavirus was the focus of a declaration of emergency by President Donald Trump in a March 13 press conference. The plan calls for sharply boosting the production of coronavirus test kits while also making tests available at a network of drive-through sites. In an address at the […]
Molecular point-of-care diagnostic solutions offer improvements in the sensitivity and specificity of existing near-patient and rapid tests while expanding the diagnostic capabilities at points of care, such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world, and are used to assess conditions or admit patients. The concept […]
March 9, 2020 — The revival of legislation to change the regulation of laboratory-developed tests (LDTs) has drawn a mixed response. The reintroduction of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act is intended to remove barriers that are believed to have impeded the U.S. government’s response to the coronavirus epidemic. The issue of diagnostics […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
